查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1732979

心臟封堵器市场－全球产业规模、份额、趋势、机会和预测，按封锁类型（先天性心臟缺陷封锁{按技术（ASD、PDA、VSD）}、PFO 封锁、LAA 封锁）按地区和竞争情况细分，2020 年至 2030 年

Heart Closure Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Closure Type (Congenital Heart Defect Closure{By Technique( ASD,PDA,VSD)},PFO Closure, LAA Closure) By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球心臟封堵器市场价值为 28.4 亿美元，预计到 2030 年将达到 51.4 亿美元，预测期内复合年增长率为 10.39%。心臟封堵器旨在治疗结构性心臟缺陷，例如心房中隔缺损 (ASD)、卵圆孔未闭 (PFO) 和室间隔缺损 (VSD)，为开胸心臟手术提供微创替代方案。由于心血管疾病发病率不断上升、导管手术的采用率不断提高、设备材料和设计的进步以及老年人口的不断增长，市场正在迅速扩张。经导管封堵装置和增强影像技术等技术创新使这些手术更加精确、侵入性更小，进一步推动了其应用。全球对减少创伤性干预和改善患者治疗效果的追求持续推动着对这些设备的需求，特别是在医疗基础设施先进且对心臟缺陷治疗认识不断提高的地区。

市场概览
预测期 2026-2030
2024年市场规模 28.4亿美元
2030年市场规模 51.4亿美元
2025-2030 年复合年增长率 10.39%
成长最快的领域 先天性心臟病 (CHD) 封堵
最大的市场 北美洲

关键市场驱动因素

技术进步

主要市场挑战

报销问题

主要市场趋势

经导管封堵器

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球心臟封堵器市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依封锁类型（先天性心臟病封堵、卵圆孔未闭 (PFO) 封堵、左心耳封堵）
    • 按公司分类（2024）
    • 按地区
  • 市场地图

第六章：北美心臟封堵器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章：欧洲心臟封堵器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太心臟封堵器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美洲心臟封堵器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东与非洲心臟封堵器市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章： 大环境分析

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • Gore & Associates, Inc.
  • Abbott Laboratories
  • AtriCure Inc.
  • Lifetech Scientific
  • Occlutech
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Heartstitch
  • SMT
  • Cardiac, Inc.
  • Boston Scientific Corporation

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 16279

The Global Heart Closure Devices Market was valued at USD 2.84 billion in 2024 and is projected to reach USD 5.14 billion by 2030, growing at a CAGR of 10.39% during the forecast period. Heart closure devices are designed to treat structural heart defects such as atrial septal defects (ASDs), patent foramen ovale (PFO), and ventricular septal defects (VSD), providing a minimally invasive alternative to open-heart surgery. The market is expanding rapidly due to the rising prevalence of cardiovascular conditions, increasing adoption of catheter-based procedures, advancements in device materials and design, and the growing geriatric population. Technological innovations, such as transcatheter closure devices and enhanced imaging techniques, are making these procedures more precise and less invasive, further driving adoption. The global push for less traumatic interventions and improved patient outcomes continues to fuel demand for these devices, especially in regions with advanced healthcare infrastructure and rising awareness about heart defect treatments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.84 Billion
Market Size 2030USD 5.14 Billion
CAGR 2025-203010.39%
Fastest Growing SegmentCHD Closure
Largest MarketNorth America

Key Market Drivers

Technological Advancements

Technological progress has significantly contributed to the expansion of the heart closure devices market. Developments in biomaterials and engineering have led to devices that are smaller, more flexible, and easier to implant, improving patient comfort and clinical outcomes. Innovations in catheter-based techniques enable minimally invasive procedures, reducing recovery time and surgical risks. Additionally, the integration of real-time imaging technologies such as 3D imaging and intracardiac echocardiography (ICE) allows for accurate visualization and placement of closure devices. These advancements have expanded treatment options for patients with congenital or acquired heart defects and have made these procedures more accessible and safer, which has helped boost overall market growth.

Key Market Challenges

Reimbursement Issues

Inconsistent and limited reimbursement policies represent a significant challenge in the heart closure devices market. Coverage and reimbursement vary widely across countries and healthcare systems, influencing patient access and the financial viability of procedures. In regions where reimbursement is limited or unclear, patients may face high out-of-pocket costs, deterring them from undergoing treatment. Healthcare providers also encounter administrative burdens and delays in securing reimbursement, which can limit their ability to offer these procedures consistently. These factors create disparities in treatment availability and restrict the adoption of heart closure devices, particularly in lower-income or publicly funded healthcare environments.

Key Market Trends

Transcatheter Closure Devices

Transcatheter closure devices are gaining prominence as the preferred approach for treating structural heart defects. These devices are delivered through catheters, offering a highly targeted and minimally invasive method of closure that reduces surgical complications and shortens recovery time. As precision and ease-of-use improve, these devices are increasingly seen as the standard of care, particularly for conditions like PFO and ASDs. Advanced delivery systems and real-time imaging facilitate accurate deployment, contributing to better procedural outcomes. The growing demand for less invasive cardiac procedures, combined with strong clinical efficacy, is driving widespread adoption of transcatheter closure technologies and accelerating their market penetration.

Key Market Players

  • Gore & Associates, Inc.
  • Abbott Laboratories
  • AtriCure Inc.
  • Lifetech Scientific
  • Occlutech
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Heartstitch
  • SMT
  • Cardiac, Inc.
  • Boston Scientific Corporation

Report Scope

In this report, the Global Heart Closure Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Heart Closure Devices Market, By Closure Type:

  • CHD Closure
  • PFO Closure
  • LAA Closure

Heart Closure Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Heart Closure Devices Market.

Available Customizations

Global Heart Closure Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Heart Closure Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 5.2.2. By Company (2024)
    • 5.2.3. By Region
  • 5.3. Market Map

6. North America Heart Closure Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Heart Closure Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Closure Type
    • 6.3.2. Mexico Heart Closure Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Closure Type
    • 6.3.3. Canada Heart Closure Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Closure Type

7. Europe Heart Closure Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Heart Closure Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Closure Type
    • 7.3.2. Germany Heart Closure Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Closure Type
    • 7.3.3. United Kingdom Heart Closure Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Closure Type
    • 7.3.4. Italy Heart Closure Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Closure Type
    • 7.3.5. Spain Heart Closure Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Closure Type

8. Asia-Pacific Heart Closure Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 8.2.2. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Heart Closure Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Closure Type
    • 8.3.2. India Heart Closure Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Closure Type
    • 8.3.3. South Korea Heart Closure Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Closure Type
    • 8.3.4. Japan Heart Closure Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Closure Type
    • 8.3.5. Australia Heart Closure Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Closure Type

9. South America Heart Closure Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Heart Closure Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Closure Type
    • 9.3.2. Argentina Heart Closure Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Closure Type
    • 9.3.3. Colombia Heart Closure Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Closure Type

10. Middle East and Africa Heart Closure Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Heart Closure Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Closure Type
    • 10.3.2. Saudi Arabia Heart Closure Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Closure Type
    • 10.3.3. UAE Heart Closure Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Closure Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Gore & Associates, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Abbott Laboratories
  • 15.3. AtriCure Inc.
  • 15.4. Lifetech Scientific
  • 15.5. Occlutech
  • 15.6. Lepu Medical Technology (Beijing) Co., Ltd.
  • 15.7. Heartstitch
  • 15.8. SMT
  • 15.9. Cardiac, Inc.
  • 15.10. Boston Scientific Corporation

16. Strategic Recommendations

17. About Us & Disclaimer